MED
Undervalued by 24.4% based on the discounted cash flow analysis.
Market cap | $353.78 Million |
---|---|
Enterprise Value | $259.34 Million |
Dividend Yield | $3.2665 (10.06%) |
Earnings per Share | $9.1 |
Beta | 0.86 |
Outstanding Shares | 10,895,595 |
Avg 30 Day Volume | 376,883 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 3.56 |
---|---|
PEG | -4.61 |
Price to Sales | 0.34 |
Price to Book Ratio | 1.86 |
Enterprise Value to Revenue | 0.24 |
Enterprise Value to EBIT | 2.05 |
Enterprise Value to Net Income | 2 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...